Lifeworks Advisors LLC Purchases 7,485 Shares of The Clorox Company $CLX

Lifeworks Advisors LLC boosted its position in The Clorox Company (NYSE:CLXFree Report) by 13.9% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 61,215 shares of the company’s stock after purchasing an additional 7,485 shares during the period. Lifeworks Advisors LLC’s holdings in Clorox were worth $6,344,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. State Street Corp grew its holdings in Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares during the period. Invesco Ltd. raised its position in shares of Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after acquiring an additional 884,751 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after purchasing an additional 10,060 shares during the period. Van ECK Associates Corp lifted its stake in shares of Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after purchasing an additional 426,433 shares during the period. Finally, Two Sigma Investments LP boosted its position in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after purchasing an additional 439,797 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently commented on CLX. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Barclays dropped their price target on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Jefferies Financial Group cut their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $103.40.

Get Our Latest Report on Clorox

Clorox Stock Up 0.0%

Shares of NYSE:CLX opened at $96.57 on Monday. The business’s 50 day simple moving average is $94.10 and its two-hundred day simple moving average is $104.11. The firm has a market cap of $11.68 billion, a P/E ratio of 15.68, a PEG ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts forecast that The Clorox Company will post 5.53 EPS for the current fiscal year.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.